Company / Current Assets
Emergent BioSolutions Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$662.5M
FY2025
5-year range
$598.7M / $1.3B
FY2021-FY2025
Trend
+10.7%
vs FY2024
Sector context
#89 of 213
Health Care
What the data says
At $663M, Emergent BioSolutions Inc.'s current assets ranks #89 of 213 in the Health Care sector. Current Assets returned to growth in FY2025 after 3 years of decline, reaching $663M.
Based on SEC 10-K filings.
$663M in FY2025 with a 5-year CAGR of -11.1%.
Declined from $680M to $663M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -18.2%
- 5-Year CAGR
- -11.1%
- 10-Year CAGR
- -
Sector benchmark
#89 of 213 in Health CareTop 42% of 213This company $662.5M Sector average $2.5B
▼
-73.7% below sector average
Key checks
Key Insights
- 5-year CAGR of -11.1%, indicating a declining trend.
- In FY2025, current assets increased 10.7% year-over-year.
- Ranks #89 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $662.5M | +10.7% |
| FY2024 | $598.7M | -11.9% |
| FY2023 | $679.5M | -43.9% |
| FY2022 | $1.2B | -4.9% |
| FY2021 | $1.3B | +6.4% |
| FY2020 | $1.2B | +74.3% |
| FY2019 | $686.2M | +10.5% |
| FY2018 | $620.8M | +27.9% |
| FY2017 | $485.4M | -4.9% |
| FY2016 | $510.2M | -5.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026